Literature DB >> 15909157

Pupil size and Perimetry--a pharmacological model using increment and decrement stimuli.

David D Martin1, Reinhard Vonthein, Helmut Wilhelm, Ulrich Schiefer.   

Abstract

BACKGROUND: To assess the influence of natural and pharmacologically induced pupil size fluctuations on differential luminance sensitivity threshold (DLS) using bright (increment) and dark (decrement) stimuli.
METHODS: Twelve healthy volunteers (20-30 years) were examined under the effect of phenylephrine 2%, dapiprazole 0.5%, and placebo. Pupil size was recorded by infra-red video camera in sessions without and with visual field examination (Tübingen Computer Campimeter). DLS was estimated at 9 locations within the central 20 degrees visual field, using bright and dark 26 min-of-arc-stimuli (10 cd/m(2) background, 4-2-1 dB thresholding strategy, four reversals).
RESULTS: There were substantial inter-individual differences in pupil size and pupil size fluctuations. Intra-individual differences were small. Independently of medication, pupil size fluctuations were reduced by more than one-third when a subject was undergoing perimetric examination. Pupil size affected DLS on its own (slope 0.21 dB/mm; 95% CI: 0.09-0.33 dB/mm), differently at different stimulus locations, and to a greater extent with increment than with decrement stimuli (slope difference 0.13 dB/mm; 95% CI: 0.00-0.26 dB/mm).
CONCLUSIONS: Campimetric examinations have a stabilising effect on pupil size fluctuations. Pupil size affects DLS with bright stimuli more than with dark stimuli; in normal young subjects this effect is not relevant for clinical or normative studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15909157     DOI: 10.1007/s00417-005-1185-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  An explicit no response instead of time-out in automated visual-field testing.

Authors:  S Lutz; T J Dietrich; N Benda; B Selig; H Strasburger; U Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-03       Impact factor: 3.117

2.  Simulated progression of visual field defects of glaucoma.

Authors:  R M DAY; H G SCHEIE
Journal:  AMA Arch Ophthalmol       Date:  1953-10

3.  Mathematical procedures in data recording and processing of pupillary fatigue waves.

Authors:  H Lüdtke; B Wilhelm; M Adler; F Schaeffel; H Wilhelm
Journal:  Vision Res       Date:  1998-10       Impact factor: 1.886

4.  Effects of pupillary dilation on automated perimetry in normal patients.

Authors:  K A Lindenmuth; G L Skuta; R Rabbani; D C Musch; T J Bergstrom
Journal:  Ophthalmology       Date:  1990-03       Impact factor: 12.079

5.  Pupillographic assessment of sleepiness in sleep-deprived healthy subjects.

Authors:  B Wilhelm; H Wilhelm; H Lüdtke; P Streicher; M Adler
Journal:  Sleep       Date:  1998-05-01       Impact factor: 5.849

6.  Effects of pupillary constriction on automated perimetry in normal eyes.

Authors:  K A Lindenmuth; G L Skuta; R Rabbani; D C Musch
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

7.  The normal visual field on the Humphrey field analyzer.

Authors:  R S Brenton; C D Phelps
Journal:  Ophthalmologica       Date:  1986       Impact factor: 3.250

8.  Automated perimetry with bright and dark stimuli.

Authors:  B Wabbels; U Schiefer; B Treutwein; N Benda; G Stercken-Sorrenti
Journal:  Ger J Ophthalmol       Date:  1995-07

9.  The effect of pilocarpine on the visual field in normals.

Authors:  D J McCluskey; J P Douglas; P S O'Connor; K Story; L M Ivy; J S Harvey
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

10.  Effect of phenylephrine on accommodation.

Authors:  J A Mordi; W M Lyle; G Y Mousa
Journal:  Am J Optom Physiol Opt       Date:  1986-04
View more
  1 in total

1.  Influence of pupil size and other test variables on visual function assessment using visual evoked potentials in normal subjects.

Authors:  Sarwat Salim; Kevin Childers; Alvaro P C Lupinacci; George Z Hu; Vance Zemon; Peter A Netland
Journal:  Doc Ophthalmol       Date:  2010-02-10       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.